---
title: "This Humana Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294358917.md"
description: "Wall Street analysts downgraded five stocks on Thursday: Paymentus (PAY) to Neutral, Masco (MAS) to In-Line with a lower price target, Fiverr (FVRR) to Perform, Humana (HUM) to Market Perform, and SiteOne Landscape Supply (SITE) to Hold with a reduced price target."
datetime: "2026-07-30T11:35:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294358917.md)
  - [en](https://longbridge.com/en/news/294358917.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294358917.md)
generator: "portal-rs"
---

# This Humana Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Baird analyst David Koning downgraded **Paymentus Holdings Inc** (NYSE:PAY) from Outperform to Neutral and maintained the price target of $34. Paymentus shares closed at $36.70 on Wednesday. See how other analysts view this stock.
-   Evercore ISI Group analyst Stephen Kim downgraded **Masco Corp** (NYSE:MAS) from Outperform to In-Line and slashed the price target from $86 to $78. Masco closed at $72.56 on Wednesday. See how other analysts view this stock.
-   Oppenheimer analyst Jason Helfstein downgraded **Fiverr International Ltd** (NYSE:FVRR) from Outperform to Perform. Fiverr Intl shares closed at $9.21 on Wednesday. See how other analysts view this stock.
-   Raymond James analyst John Ransom downgraded **Humana Inc** (NYSE:HUM) from Outperform to Market Perform. Humana shares closed at $365.41 on Wednesday. See how other analysts view this stock.
-   Stifel analyst W. Andrew Carter downgraded **SiteOne Landscape Supply, Inc.** (NYSE:SITE) from Buy to Hold and cut the price target from $153 to $100. SiteOne Landscape Supply shares closed at $93.79 on Wednesday. See how other analysts view this stock.

Considering buying HUM stock? Here’s what analysts think:

*Photo via Shutterstock*

### Related Stocks

- [HUM.US](https://longbridge.com/en/quote/HUM.US.md)
- [FVRR.US](https://longbridge.com/en/quote/FVRR.US.md)
- [SITE.US](https://longbridge.com/en/quote/SITE.US.md)
- [PAY.US](https://longbridge.com/en/quote/PAY.US.md)
- [MAS.US](https://longbridge.com/en/quote/MAS.US.md)

## Related News & Research

- [Masco Rated Hold as Solid Fundamentals Meet Full Valuation; Analyst Sees Shares Range-Bound Around $80 Target](https://longbridge.com/en/news/296828324.md)
- [Ambea publishes offer document, prospectus for Humana takeover bid](https://longbridge.com/en/news/296795928.md)
- [Humana Inc. $HUM Shares Sold by Handelsbanken Fonder AB](https://longbridge.com/en/news/296327657.md)
- [Humana (HUM) Could Be 25% Overvalued As Lower EPS Guidance Clouds Results](https://longbridge.com/en/news/295329343.md)
- [Paymentus Holdings, Inc. (NYSE:PAY) Receives Average Recommendation of "Moderate Buy" from Analysts](https://longbridge.com/en/news/296755057.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**